ClearPoint Neuro, Inc. - Common Stock, $0.01 par value (CLPT) Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2020 to Q4 2025

Type / Class
Equity / Common Stock, $0.01 par value
Symbol
CLPT on Nasdaq
Shares outstanding
28,234,434
Price per share
$13.68
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
9,852,347
Total reported value
$214,616,813
% of total 13F portfolios
0%
Share change
+605,672
Value change
+$19,210,930
Number of holders
106
Price from insider filings
$13.68
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of ClearPoint Neuro, Inc. - Common Stock, $0.01 par value (CLPT) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BIGGER CAPITAL FUND L P 7.6% -1.2% $46,757,352 +$77,986 2,145,817 +0.17% Bigger Michael 30 Sep 2025
BlackRock, Inc. 5.6% $24,352,856 1,583,071 BlackRock, Inc. 30 Jun 2025
VANGUARD GROUP INC 5.3% $17,612,933 1,475,120 The Vanguard Group 30 Jun 2025

As of 30 Sep 2025, 106 institutional investors reported holding 9,852,347 shares of ClearPoint Neuro, Inc. - Common Stock, $0.01 par value (CLPT). This represents 35% of the company’s total 28,234,434 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of ClearPoint Neuro, Inc. - Common Stock, $0.01 par value (CLPT) together control 30% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
BlackRock, Inc. 6.6% 1,861,746 +7.4% 0% $40,567,446
VANGUARD GROUP INC 5.3% 1,497,637 +1.5% 0% $32,633,511
GEODE CAPITAL MANAGEMENT, LLC 2.3% 656,397 +5.1% 0% $14,305,425
STATE STREET CORP 1.7% 482,650 +45% 0% $10,516,944
UBS Group AG 1.3% 360,705 +132% 0% $7,859,762
BROWN ADVISORY INC 1.2% 330,727 -0.05% 0.01% $7,206,542
Lane Generational LLC 1.1% 311,885 +21% 5.6% $6,795,974
TWO SIGMA INVESTMENTS, LP 1.1% 310,526 +1316% 0.01% $6,766,362
BOONE CAPITAL MANAGEMENT LLC 1% 283,912 2% $6,186,442
MORGAN STANLEY 0.83% 235,281 -29% 0% $5,126,773
ESSEX INVESTMENT MANAGEMENT CO LLC 0.82% 232,458 -29% 0.78% $5,065,260
DEUTSCHE BANK AG\ 0.82% 232,287 +815% 0% $5,061,534
Informed Momentum Co LLC 0.75% 211,664 0.52% $4,559,042
NORTHERN TRUST CORP 0.73% 205,836 +0.53% 0% $4,485,167
MILLENNIUM MANAGEMENT LLC 0.67% 187,801 +88% 0% $4,092,184
CONWAY CAPITAL MANAGEMENT, INC. 0.52% 146,425 -11% 1.3% $3,190,601
PARSONS CAPITAL MANAGEMENT INC/RI 0.51% 142,736 -0.52% 0.18% $3,110,218
Taylor Frigon Capital Management LLC 0.47% 134,024 -26% 1.5% $2,920,383
TWO SIGMA ADVISERS, LP 0.47% 132,400 0.01% $2,884,996
BNP PARIBAS FINANCIAL MARKETS 0.39% 110,501 0% 0% $2,407,817
GOLDMAN SACHS GROUP INC 0.37% 105,107 -63% 0% $2,290,281
Financial Engines Advisors L.L.C. 0.37% 104,814 -58% 0% $2,283,897
Bank of New York Mellon Corp 0.37% 104,150 +5.2% 0% $2,269,426
CITADEL ADVISORS LLC 0.31% 86,492 +8.7% 0% $1,884,660
CM Management, LLC 0.28% 80,000 -60% 1.5% $1,743,200

Institutional Holders of ClearPoint Neuro, Inc. - Common Stock, $0.01 par value (CLPT) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 155,543 $2,127,828 -$47,703 $13.68 4
2025 Q3 9,852,347 $214,616,813 +$19,210,930 $21.79 106
2025 Q2 9,158,528 $109,328,754 +$14,491,053 $11.94 96
2025 Q1 8,192,663 $97,509,520 +$5,576,522 $11.89 101
2024 Q4 7,604,982 $116,965,932 +$12,952,321 $15.38 89
2024 Q3 6,824,887 $76,506,571 -$722,998 $11.21 78
2024 Q2 7,054,815 $38,032,671 -$3,182,534 $5.39 82
2024 Q1 7,537,566 $51,255,965 +$8,355,957 $6.80 80
2023 Q4 6,294,172 $42,743,970 +$2,471,846 $6.79 69
2023 Q3 5,945,334 $29,812,011 +$1,413,167 $5.01 62
2023 Q2 5,807,940 $42,048,347 +$7,782,251 $7.24 60
2023 Q1 4,610,777 $38,915,035 +$3,180,292 $8.44 59
2022 Q4 4,233,376 $36,002,568 +$2,658,961 $8.47 62
2022 Q3 3,823,775 $39,609,709 +$2,929,976 $10.36 52
2022 Q2 3,481,751 $45,435,169 -$14,747,696 $13.05 44
2022 Q1 4,754,849 $49,447,250 -$533,820 $10.41 61
2021 Q4 4,769,266 $53,493,964 -$12,166,751 $11.22 65
2021 Q3 5,487,089 $97,479,919 +$2,463,812 $17.75 68
2021 Q2 5,322,434 $101,536,402 +$42,321,910 $19.09 75
2021 Q1 3,102,980 $65,594,982 +$19,961,387 $21.14 50
2020 Q4 2,274,660 $36,144,244 +$16,455,073 $15.89 38
2020 Q3 992,026 $5,416,000 -$335,510 $5.46 25
2020 Q2 1,142,056 $4,063,000 -$489,528 $3.56 24
2020 Q1 1,278,400 $4,646,000 +$4,642,000 $3.59 25